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Summary
Background Type 2 T-helper cells (Th2) are involved in the regulation of the humoral
immune response against antigens and allergens and directly affect which isotype will be
produced. The mechanism that regulates antigen-speci®c IgE secretion and immune
deviation is still not known.
Objectives To delineate mechanisms behind antigen-speci®c IgE secretion we have used
in vitro immunization and focused on T-cell phenotype and the activation status of the
transcription factor NFkB.
Methods Peripheral blood lymphocytes (PBMC) from seronegative donors were immu-
nized in vitro with a peptide consisting of both a T-cell and a B-cell epitope.
Results Antigen-speci®c IgE antibodies could be detected after a primary immunization,
during which T-helper cells secreted type 2 cytokines. Speci®c IgE was also detected in the
secondary immunization, but due to a rapid polarization from Th2 to Th1 phenotype,
exogenous IL-4 was required for the speci®c IgE secretion. Analysis of NFkB activation in
B and T cells during primary and secondary immunization showed that NFkB could be
detected in both B and T cells during primary immunization, but was dependent on
exogenous IL-4 in the secondary immunization.
Conclusion This is the ®rst evidence of antigen-speci®c IgE induction in vitro using naive
B cells, demonstrating the involvement of T-helper cell phenotype and NFkB and
demonstrates the usefulness of in vitro cultures to study the effect of antigens on human
immunocytes.
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Introduction
The speci®c immune response to an antigen is largely
dependent on activation of T-helper cells that are able to
secrete necessary cytokines [1]. The balance between
humoral and cellular immunity is orchestrated by cytokines
derived from CD4T cells (Th), which have been further
subdivided into Th1 and Th2 cells [2,3]. Th1 cells particular
secrete IFNg and TNFa/b, which promote in¯ammatory
cellular immunity and protect against, e.g. intracellular
microorganisms and cancer. Th2 cells, with a lymphokine
production skewed towards IL-4 and IL-13, are involved in
humoral immunity and the elimination of extracellular
pathogens and also in reducing the risk of Th1 cell-mediated
autoimmunity [1]. Atopic allergy to normally harmless
proteins is correlated to the development of polarized Th2
with high production of type-2 lymphokines, resulting in
antigen-speci®c IgE secretion. The immune deviation [4]
seen in the neonatal immune response of nonatopics is
biased towards Th2 responses, which shifts towards Th1
during the ®rst year of life, while atopic children retain their
Th2 response [4]. The mechanisms involved in the devel-
opment of polarized T helper cells, in particular Th2 cells,
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as well as of the subsequent antigen-speci®c IgE secretion
need further elucidation and prompted us to investigate
these questions using an in vitro approach.
In the present study we used the in vitro immunization
system, initially designed to induce antigen-speci®c isotype
switch from m to g [5], to also study the induction of
speci®c IgE secretion. The switching to e isotype is
dependent on lymphokines as well as receptor-mediated
signals and it has recently been shown that ligation of
CD40 by CD40L, in the presence of soluble IL-4, leads to
activation of the transcription factor NFkB. This factor
binds to the e-promoter inducing transcription of the
unrearranged constant region gene [6±9]. This transcrip-
tion facilitates recombination of the variable-region gene 50
of the expressed IgE constant-region, which will ultimately
lead to expression of mature IgE antibodies. CD40 is thus a
central player in regulating IgE production. The impor-
tance of NFkB in mediating the effects of CD40 ligation is
emphasized by a study, which shows that NFkB knockout
mice have defects in isotype switching [10]. In addition to
its direct role in B cells, NFkB may also have an indirect
in¯uence on isotype switching by its effects in T cells [11].
The basis of the present in vitro immunization system is a
cognate interaction between T and B cells, supported by
the use of a heterotope peptide containing a T-helper cell
recall epitope and the speci®c B-cell antigen epitope. The
speci®c B-cell response is driven by antigen activated T
cells and recognition of the B-cell epitope by surface
immunoglobulin [12]. We have studied the antigen-speci®c
induction of IgE, using a similar approach, including
phenotypic analysis of Th cells during both the primary
and secondary in vitro immunization [13]. The activation
status of NFkB in both T cells and B cells was also probed
after different stimulation periods to correlate the activa-
tion of NFkB with progression of T-cell differentiation and
isotype switching.
Materials and methods
Antibodies, antigens and cytokines
FITC-labelled anti-CD19, anti-CD14 and anti-CD16 anti-
bodies and the R-phycoerythrin (RPE)-labelled anti-CD3
antibody were obtained from Dako A/S (Glostrup,
Denmark). Anti-CD3 FITC was purchased from Becton
Dickinson Inc. (San Jose, CA, USA). Anti-CD4 tricolour
(TC), was purchased from Caltag (San Francisco, CA,
USA). Anti-IL-4-RPE and anti-IFNg-RPE were purchased
from Pharmingen (San Diego, CA, USA). The S2C6 anti-
CD40 mAb was a generous gift from Dr Staffan Paulie
(Stockholm University, Sweden). Peptide antigens pTT,
pV3 and pTT-pV3 were kindly provided by Dr Elias
Krambovitis (Institute of Molecular Biology and Biotech-
nology, Greece). The peptides are shown in Table 1. pB1, a
recombinant protein containing most of the C-terminal part
of the gp120 (HIV-1) was a generous gift from Repligen Inc.
Tetanus toxoid (TT) was purchased from the Swedish
Institute for Infectious Disease Control (Stockholm,
Sweden). IL-4 was obtained from Genzyme (Cambridge,
MA, USA).
Cells and medium
Buffy coats were obtained from healthy, HIV-1 seronega-
tive donors from the University Hospital Blood Bank
(Lund, Sweden). All sera were initially tested in ELISA
for antibodies against TT. Peripheral blood mononuclear
cells (PBMC) from TT-positive donors were isolated as
described previously [13]. Brie¯y, PBMC were separated
from red blood cells on Ficoll-Paque (Pharmacia, Uppsala,
Sweden) by density centrifugation. The isolated PBMC
were incubated in RPMI 1640, containing 2% human
serum, together with freshly prepared 0.175 mM L-leucyl-
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Table 1. Peptides used in the in vitro immunization and the antigen-speci®c IgE ELISA
Peptide Sequence Antigen
pTT QYIKANSKTEL Tetanus toxoid
pV3 RKSIRIQRGPGRAFV HIV-1 gp(aa.304±318)
pTT-pV3 QYIKANSKTELRKSIRIQRGPGRAFV Heterotope of pTT and pV3
pB1 QLNQSVEINCTRPNNNTRKSIRIQRGPGR HIV-1 gp 120






L-leucine methyl esterhydrobromide (LLOMe) (Bachem
Feinchemikalien AG, Budendorf, Switzerland), for 15 min
at room temperature and then washed three times. After
resuspension in medium, containing 10% human serum, the
cells were incubated for 2 h at 37 8C to increase the viability
of the cell preparation.
RPMI 1640, supplemented with 4 mM L-glutamine,
nonessential amino acids, 50 mg/mL gentamycin (Biolo-
gical Industries, Haemek, Israel), 10% heat inactivated
human serum (University Hospital Bloodbank, Lund,
Sweden) or fetal calf serum (Gibco, Grand Island, NY,
USA) was used in all cell cultures unless otherwise
stated.
Primary in vitro immunization
3 ´ 106 LLOMe-treated cells were cultured for 7 days in
medium containing 10% human serum, 50 mM 2-mercapto-
ethanol, 40 ng IL-2/mL, 25% T-cell replacing factor (TRF)
[5±13]. The cells were immunized with 7 nM pTT-pV3
peptide.
Generation of activated T-helper cells for the secondary
immunization
T cells in the LLOMe treated cell population were activated
by culturing 1 ´ 106 cells/mL together with 1 ´ 106/mL
feeder cells (irradiated autologous PBMC) in tissue culture
¯asks with 50 mM 2-mercaptoethanol and 10 mM pTT for
7 days [12]. At day 3, fresh complete culture medium was
added to the cultures.
Secondary in vitro immunization
Primary immunized cells as well as the activated T cells
were harvested and centrifuged through 40% Ficoll-Paque,
at day 7. After one wash, the proportion of B and T cell
was determined by FACS analysis. 0.5 ´ 106/mL cells from
the primary immunization were cocultured together with
0.2 ´ 106/mL T cells from the antigen-speci®c T-cell
activation on a monolayer of irradiated CD32-transfected
®broblasts for a secondary immunization period. The cells
were cultured for 4 days in medium, supplemented with 5%
human serum, 50 mM 2-mercaptoethanol, 7 nM pTT-pV3
and 0.5 mg/mL anti-CD40 antibody, with and without the
supplementation of 100 U IL-4/mL.
A population of primary and secondary immunized cells
were infected with EBV, as described previously [14], and
cultured for 10±20 days in presence of irradiated feeder
cells in medium containing fetal calf serum. The culture
supernatant was then removed and analysed for total as well
as antigen-speci®c human IgE antibodies.
Intracellular staining
T cells were analysed for intracellular cytokines, as
described previously [15]. Cells from primary and second-
ary immunization were treated with 20 ng/mL PMA
and 16 mM/L ionomycin (Sigma-Aldrich Chemie, Germany)
over night. Two hours before harvesting the cells, Brefeldin
A 5 mg/mL (Sigma-Aldrich Chemie) was added. The cells
were washed with PBS supplemented with 1% BSA and
stained with anti-CD3 FITC. The cells were washed twice
and ®xed with 2% formaldehyde for 15 min and then
permeabilized after a wash, with 0.5% Tween for 45 min.
The cells were then incubated with anti-IL-4 or anti-IFNg
antibodies. After a 30-min incubation in the dark, the cells
were washed and analysed by ¯ow cytometry, using a
FACScan (Beckton Dickinson Inc.).
Preparation of nuclear fractions for NFkB analysis
B and T cells from primary and secondary cultures were
separated with anti-CD19 and anti-CD3 magnetic beads
(Dynal A.S., Oslo, Norway), respectively. After separa-
tion, 0.5±1 ´ 106 cells were centrifuged at 1500 g for
5 min and the cells resuspended in 1 mL hypotonic
buffer (10 mM HEPES-NaOH buffer, pH 7.9, containing
1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol and
0.5 mM PMSF). Cells were pelleted by centrifugation at
14000 g for 10 min and then lysed for 10 min on ice in
hypotonic buffer (20 mL), containing 0.1% (v/v) Nonidet
P-40. Lysates were centrifuged at 14000 g for 10 min. The
resulting pellets were resuspended in 20 mM HEPES-
NaOH buffer, pH 7.9 (15 mL), containing 420 mM NaCl,
1.5 mM MgCl2, 0.2 mM EDTA, 25% (w/v) glycerol and
0.5 mM PMSF and incubated for 15 min on ice. The
nuclear suspensions were then centrifuged at 14000 g for
10 min and the supernatants were transferred into 10 mM
HEPES/NaOH buffer, pH 7.9 (75 mL), containing 50 mM
KCl, 0.2 mM EDTA, 20% (w/v) glycerol, 0.5 mM PMSF
and 0.5 mM dithiothreitol. Such samples constituted of
nuclear extracts. Protein concentrations of nuclear extracts
were determined [16] and the extracts assayed immedi-
ately for NFkB activity or stored at ÿ 70 8C until further
use. All of the steps in the above procedure were
performed at 4 8C, unless otherwise stated.
Electrophoretic mobility shift assay
Nuclear extracts (4 mg protein) were incubated with
20 000 c.p.m. of a 22-bp oligonucleotide containing the
NFkB consensus sequence, which had been previously
labelled with [g-32P]ATP (10 mCi/mmol) by T4 poly-
nucleotide kinase [17]. Incubations were performed for
30 min at room temperature in the presence of 2 mg poly
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(dI-dC) and 10 mM Tris-HCl buffer, pH 7.5, containing
100 mM NaCl, 1 mM EDTA, 5 mM dithiothreitol, 4% (w/v)
glycerol and 0.1 mg/mL nuclease-free BSA. All incubations
were subjected to electrophoresis on 4% (w/v) polyacryl-
amide gels, which were subsequently dried and autoradio-
graphed.
Detection of antigen-speci®c antibodies with ELISA
ELISA was performed by coating microtitre plates (Life
Technologies, Sweden) with 70 ng pB1/well or 1 mg bovine
serum albumin/well or 0.05 mg rabbit antihuman IgE/well
(Dako A/S Glostrup, Denmark) in sodium carbonate buffer,
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Fig. 1. General outline of the experimental set up utilized to study antigen-speci®c IgE induction.
Table 2. IgE switch frequency after primary and secondary immunization detected by ELISA
Secondary Secondary
Primary immunization immunization
immunization with IL-4 without IL-4
IgETOT IgEV3 IgETOT IgEV3 IgETOT IgEV3
Donor % No. of wells % No. of wells % No. of wells % No. of wells % No. of wells % No. of wells
A 15 58/378 3.4 13/378 3.9 4/102 0 0/102 8.3 5/60 0 0/60
B 1.7 12/702 1.6 11/702 43 13/30 17 5/30 8.3 2/24 0 0/24
C 1.8 1/54 1.8 1/54 0 0/162 0 0/162 0.6 1/162 1.2 2/162
D 6.1 10/162 3.1 5/162 4.6 5/108 1.9 2/108 0 0/108 0.1 1/108
E 12.5 27/216 3.1 5/162 3.7 4/108 0 0/108 0 0/108 0 0/108
F 45 73/162 0.6 1/162 2.2 3/138 0.72 1/138 0 0/132 0.75 1/132
G 0 0/216 0.5 1/216 3.1 5/162 0.61 1/162 1.9 3/162 0 0/162
H 3.7 10/270 1.8 5/270 6.8 13/192 1.0 2/192 0 0/186 0 0/186
Wells containing total and speci®c IgE antibodies/total number of wells after EBV-transformation given as numbers or percentages. Wells
were considered positive if the OD was higher than ´ (medium control) 10 ´ SD (medium control).
pH 8.6, over night at 4 8C. Coated plates were incubated for
1±2 h in 37 8C with culture supernatants, diluted three times
in PBS pH 7, containinmg 1% BSA. After washing, the
plates were incubated with horse-radish peroxidase (HRP)
conjugated rabbit antihuman-IgE (1 : 2000) (Dako A/S).
Ortho-phenylendiamine (OPD) and hydrogen peroxide
(Sigma) was added to each well, as chromogen and sub-
strate, for 15 min. The reaction was stopped by adding
150 mL 1 M sulphuric acid and the absorbance was measured
at 490 nm.
Detection of TT antibodies in sera was performed as
described previously [12].
Results
Induction of antigen-speci®c IgE by in vitro immunization
A schematic representation of the in vitro immunization
system used in this study is outlined in Fig. 1. During the
primary stimulation period (day 1±7) B cells receive signals
from the antigen, T cells and exogenously added lympho-
kines, mainly IL-2 [5], whereas the secondary period (day
8±11) provided signals by the antigen, antigen-speci®cally
activated T cells and CD40 ligation. The result of this
stimulation was analysed as the frequency of B cells
producing antigen-speci®c IgE as well as total IgE and is
shown in Table 2. Antigen-speci®c IgE antibodies could be
detected after both primary and secondary immunization,
where the frequency of B cells producing speci®c antibodies
varied between individual donors. The frequency of anti-
gen-speci®c B cell clones decreased, however, signi®cantly
during the secondary stimulation period. This could be
reversed when IL-4 was allowed to be present during day
8±11 and then the mean frequency of B cells secreting
antigen-speci®c IgE increased > 10 times, demonstrating
that the switch to an e isotype was IL-4 dependent in vitro.
The reactivity index (RI) of antigen-speci®c IgE antibodies
produced by the in vitro immunization was also determined.
The RI-values correlate to the amount of IgE detected
in vitro and/or to the antibody af®nity of the secreted IgE.
The responses were in general very strong with several
clones exhibiting RI > 50 (Table 3).
Rapid Th1 polarization occurs during the secondary
immunization period
To investigate why the secondary immunization was depen-
dent on exogenously added IL-4 we monitored the Th
phenotype during the different stimulation periods. Cells
were stained for CD3, ®xed and analysed for intracellular
cytokines. Thirty to 50% of T cells from primary immunized
cultures (day 7) were positive for intracellular IL-4 but < 5%
of the CD3 T cells produced IFNg (Fig. 2), indicating
that the major phenotype was Th2. The separately generated
antigen-speci®c Th cells had also a Th2 cytokine pro®le at
the initiation of the secondary immunization, which was
comparable to the Th cells present during the primary
immunization period. Cells were then harvested after the
secondary immunization period (day 11) and the cytokine
pro®le was analysed. At this time point, i.e. 11 days after
initiation, > 60% of the Th cells in the cultures were now
IFNg positive, whereas less than 2% were positive for
intracellular IL-4 (Fig. 2). This very rapid polarization of
cytokine pro®le occurred over only 4 days and was inde-
pendently of exogenously added IL-4 to the secondary
cultures, i.e. the majority of Th cells was of Th1 phenotype
even if 100 U IL-4 had been present. Further attempts were
also made to inhibit the Th polarization by modulating some
of the other signalling pathways possibly involved in the
observed immune deviation during the secondary immuni-
zation period. Therefore, the polarization was analysed
after, (i) removal of the CD40 signalling and (ii) addition
of blocking anti-IL-12 antibodies (50 mg/mL). The polariza-
tion from a Th2 to a Th1 phenotype was, however, unaf-
fected by these attempts (data not shown).
Activation of NFkB in T and B cells is dependent on IL-4
To further study the effect of IL-4 on signalling pathways,
during the in vitro induction of antigen-speci®c IgE, we
analysed the presence of NFkB a transcription factor known
to be involved in the inducible transcription of a variety of
genes, including the e isotype and IL-2, a Th1-type cytokine.
Nuclear extracts from T cells which had been subjected to
primary immunization showed detectable levels of NFkB, as
determined by electrophoretic mobility shift assay. These
levels of NFkB were independent of exogenously added
IL-4. However, during the secondary in vitro immunization
IL-4 promoted an increased activation of NFkB in Th cells.
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Table 3. Reactivity Index (RI)* of in cultures after primary and
secondary immunization
RI values²
Culture > 5 > 50
18 immunization 17/42 4/42
28 immunization  IL-4 10/12 2/12
28 immunization ÿ IL-4 2/2 0/2
*RI was calculated as [OD(peptide speci®c IgE)-OD(medium
control against pB1)]/[OD(BSA)-OD(medium control against
BSA)]. Number of antigen-speci®c wells with a reactivity index
(RI) above 5 or 50 were then determined. ²Total values from eight
individual experiments, using different donors.
Interestingly, this activation was characterized by increased
levels of one speci®c DNA-protein complex of highest
electrophoretic mobility, indicating the ability of IL-4 to
differentially induce one of the DNA-protein complexes
(Fig. 3). Similarly, nuclear extracts from primary immu-
nized naive B cells showed high levels of activated NFkB,
where the normal presence of several DNA-protein com-
plexes are evident (Fig. 3). The levels were again indepen-
dent of IL-4 during the primary immunization period.
However, the levels of NFkB in nuclear extracts from B
cells following secondary immunization were highly depen-
dent on IL-4. The presence of IL-4 during secondary
immunization induced B cells with signi®cantly higher
levels of NFkB, relative to cells derived from an immuniza-
tion protocol where IL-4 was absent. This lends further
support to the observation of increased frequency of B cell
clones secreting IgE in the presence of IL-4 (Table 2).
Discussion
The induction of IgE in human B cells is mediated by a
cognate interaction with Th2 helper cells. These T cells
deliver signals by ligating the CD40 molecule on B cells and
by secreting IL-4, the latter being a crucial signal for isotype
switching to IgE [9]. Other signals that have been implicated
to play a role in the regulation of IgE production are, e.g.
CD21/CD23 interaction, IFNg, LFA-1/ICAM±1 interac-
tion, as well as the nature of the antigen itself [18±21].
The mechanisms behind isotype switching and IgE secre-
tion have been extensively studied, although the focus
predominantly has been on total IgE secretion and very
little data exists on antigen-speci®c IgE induction. In
particularly, dissection of this response in vitro needs to
be performed, since any differential mechanisms behind
antigen and allergen could be elucidated in a more con-
trolled environment. It was, e.g. recently demonstrated that
CD2 stimulated T cells together with CD40 and allergen
stimulated B cells induce speci®c IgE production in an IL-4
dependent manner [22]. This speci®c IgE production was
dependent on a low dose of allergen and optimal T-cell
stimulation, indicating a delicate control of speci®c IgE
synthesis. The in vitro system used in the present investiga-
tion is based on antigen activation of both T and B cells,
using a recall antigenic epitope for T-cell activation, and has
previously been shown to induce antigen-speci®c isotype
switch from m to g [5,12,13]. The earlier studies focused on
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Fig. 2. Cytokine synthesis of T cells during primary and secondary immunization. Cells were removed from cultures after primary and
secondary immunization, and stained for CD3 expression. After ®xation and permeabilization the cells were incubated with anti-IL-4 and
anti-IFNg antibodies and the presence of intracellular cytokines was determined by FACS analysis.
dissecting the signalling mechanism required for isotype
switching from m to g, whereas in the present investigation
we have studied the T-cell phenotype, transcription factor
activation and effect of cytokines known to affect isotype
switching to e. In this study, we could detect antigen-
speci®c IgE antibodies after both primary and secondary
immunization periods, where the frequency of B cells
producing speci®c IgE varied between individual donors,
as also was observed previously [5]. This indicates that
the cells can undergo immunoglobulin class switching
within 7 days of culture, since the presence of pre-
switched IgEB-cells speci®c for the V3-peptide in sero-
negative donors is unlikely. Interestingly, we see after
the secondary immunization period (day 8±11) that the
ratio of B cells secreting antigen-speci®c IgE compared to
total IgE increased, indicating an antigen-driven IgE induc-
tion. The RI values for the speci®c IgE antibody responses
were generally very strong with clones showing RI > 50,
which is considerably higher compared with RI-index for
antigen-speci®c IgG antibodies induced by in vitro immu-
nization, as previously reported [5,12].
Furthermore, the frequency of B-cell clones secreting
detectable levels of antigen-speci®c IgE was > 10 times
higher when soluble IL-4 was present during the secondary
culture period. Exogeneously added IL-4 also substantially
increased the intracellular levels of NFkB, which is known
to be directly involved in the transcription of e isotypes. The
reason that the secondary stimulation period required
addition of IL-4 to support any signi®cant antigen-speci®c
IgE secretion was most probably due to the rapid T-helper
cell polarization from Th2 to Th1 that was observed. This is
also supported by the fact that the level of IgE synthesis
is proportional to the number of Th2 cells added to B cells
and the help of Th1 cells is limited by their cytolytic
capacity [23].
The phenotype of the T-helper cells was monitored
during the culture period, since the subtype of helper cell
is crucial to the induction of a humoral immune response
in vitro. We found that after the primary immunization the
majority of the T cells were of a Th2 phenotype but after an
additional 4 day culture period, together with antigen-
stimulated Th2 cells and anti-CD40 antibodies, the Th
cells exhibited a rapid polarization and initiated a secretion
of IFNg, a Th1 cytokine. Addition of exogenous IL-4
during the secondary immunization could not reverse this
differentiation towards a Th1 phenotype. It is also well
established that IL-12 induces IFNg production in T cells
and promotes a Th1 cytokine pro®le [24]. Therefore, we
added a blocking anti-IL-12 antibody to the secondary
culture in an attempt to prevent the rapid Th1 polarization.
Also CD40 signalling of B cells has been shown to induce
IL-12 production in human B cells. Addition of anti-IL-12
antibodies as well as removing the anti-CD40 antibodies
and the ®broblasts from the secondary cultures failed to
prevent the Th2 to Th1 polarization. One possible explana-
tion, presently under investigation, is that the `default mode'
of T-helper cells is Th1, which is indicated by the rapid
in vitro polarization. The immune deviation we see in our
culture system is similar in concept to what Holt and
Macaubas discussed for the in vivo situation in a recent
review [25]. They suggested that during infancy, low levels
of environmental allergens pass the placenta barrier and
together with Th1 inhibitory factors generate T-helper
cells skewed towards Th2. An immune deviation after
birth will then result in a Th1-skewed memory. It was
also recently demonstrated that the Th2-skewed response
to common environmental allergens was present in all
new born infants suggesting that the key aetiological
factor in atopic disease may not be the initial allergen-
speci®c Th2-skewed immunity but rather the ef®ciency of
the underlying mechanisms responsible for the immune
deviation [26].
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Fig. 3. NFkB activation is dependent on additional IL-4 during
secondary but not in primary immunized cultures. B and T cells
from in vitro immunized cultures were separated, nuclear extracts
prepared and examined for NFkB binding activity, as described in
Materials and Methods. Arrows represent at least three different
DNA-protein complexes of NFkB bound to DNA and the arrow
head at the bottom of the ®gure shows unbound oligonucleotide.
When NFkB activation was analysed in both T and B cells
it was clear that NFkB was present in the cells during the
primary immunization and addition of IL-4 to those cultures
did not seem to enhance the expression. In contrast, addition
of IL-4-promoted enhanced NFkB activation in both B and
T cells during the secondary immunization. These observa-
tions were also supported by Iciek and coworkers [7] who
showed that CD40 cross-linking induced e transcripts via
activation of NFkB in synergy with IL-4. Thus it seems as if
the T cells in the present assay, during primary immuniza-
tion, have the proper phenotype to provide B cells with
suf®cient CD40 stimulation and cytokines to activate
NFkB, which then promotes IgE switching. However, the
T cells rapidly acquired a Th1 phenotype during secondary
immunization, which results in the lack of NFkB in B and T
cells during the secondary immunization in cultures not
supplemented with IL-4.
In summary, we show that the Th1/Th2 ratio play a
fundamental role in the regulation of antigen-speci®c IgE
synthesis in vitro. Furthermore, the data indicate an antigen-
driven stimulation of the speci®c B cells, where the speci®c
IgE secretion was increased by IL-4. In vitro studies might
thus play a role when dissecting mechanisms underlying
antigen-speci®c IgE induction and immune deviation.
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